CooperCompanies Stock - analyst price target trims but upside remains
Published on 06/17/2026 at 17:53 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 17:52 CET. Details in the imprint.
CooperCompanies (US21664P1039) appears against a backdrop of a slightly reduced 12-month average price target, yet analysts still project room for gains from today’s level. According to a recent TradingView consensus snapshot, the new target implies a mid-teens percentage upside for the medical device group.
All news and analysis on CooperCompanies stock
Key figures, news and background on CooperCompanies stock, including recent analyst consensus changes and sector positioning, can be found in the dedicated topic area.
What TradingView reports on targets
According to a TradingView consensus update, The Cooper Companies, Inc. average 12-month price target has been cut from $79.21 to $78.77, with individual forecasts presently spanning from $66 to $92 per share. TradingView price-target snapshot
Despite the small downward adjustment of roughly $0.44 in the average target, TradingView calculates that the revised consensus still implies about 17% upside versus the latest reference price used in that report. TradingView price-target snapshot
How the analyst consensus looks today
On this Tuesday focus, the updated target corridor suggests a still-supportive, though slightly more cautious, stance from covering analysts. The lower end at $66 would cap near-term downside, while $92 on the high side underscores continued confidence in the long-term earnings path.
External data providers put CooperCompanies’ market capitalization at around $13.1 billion in mid-June 2026, leaving the group firmly in mid-cap territory on the New York Stock Exchange and broadly aligned with other specialized medical technology names. CompaniesMarketCap overview
How the company makes money
CooperCompanies generates most of its revenue through two operating segments: CooperVision, which sells soft contact lenses for conditions such as myopia, hyperopia and astigmatism, and CooperSurgical, which focuses on fertility, women’s health and family-planning medical products.
Where the stock trades today
The shares of CooperCompanies (US21664P1039) trade on the New York Stock Exchange at approximately $67.35 as of 06/17/2026, 17:30 CET.
Key facts on CooperCompanies stock
- Company: The Cooper Companies, Inc.
- ISIN: US21664P1039
- WKN: 867245
- Ticker: COO
- Venue: NYSE
- Price (as of 06/17/2026, 17:30 CET): 67.35 USD
- Market cap: 13,130,000,000 USD (as of 06/16/2026)
- Sector / Industry: Health Care - Medical Devices
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
